DOW JONES22,679.99+1627.46 7.73%
S&P 5002,663.68+175.03 7.03%
NASDAQ7,913.24+540.16 7.33%

BridgeBio Pharma Q4 EPS $(0.62) Beats $(0.7) Estimate, Sales $13.819M

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.7) by 11.43 percent. The company reported $13.819 million in sales this quarter.

Benzinga · 03/02/2020 13:30

BridgeBio Pharma (NASDAQ:BBIO) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.7) by 11.43 percent. The company reported $13.819 million in sales this quarter.